Citation: Mz. Wrona et G. Dryhurst, A putative metabolite of serotonin, tryptamine-4,5-dione, is an irreversible inhibitor of tryptophan hydroxylase: Possible relevance to the serotonergic neurotoxicity of methamphetamine, CHEM RES T, 14(9), 2001, pp. 1184-1192
Citation: F. Zhang et G. Dryhurst, Chromatographic separation and spectrometric identification of the oxidation products from a tetrahydro-isoquinoline alkaloid, J PHARM B, 25(2), 2001, pp. 181-189
Citation: Xm. Shen et G. Dryhurst, Influence of glutathione on the oxidation chemistry of 5-S-cysteinyldopamine: potentially neuroprotective reactions of relevance to Parkinson's disease, TETRAHEDRON, 57(2), 2001, pp. 393-405
Citation: Wk. Xin et al., Oxidative metabolites of 5-S-cysteinylnorepinephrine are irreversible inhibitors of mitochondrial complex I and the alpha-ketoglutarate dehydrogenaseand pyruvate dehydrogenase complexes: Possible implications for neurodegenerative brain disorders, CHEM RES T, 13(8), 2000, pp. 749-760
Citation: Xm. Shen et al., Oxidative metabolites of 5-S-cysteinyldopamine inhibit the alpha-ketoglutarate dehydrogenase complex: possible relevance to the pathogenesis of Parkinson's disease, J NEURAL TR, 107(8-9), 2000, pp. 959-978
Authors:
Dryhurst, G
Shen, XM
Li, H
Yang, ZL
Han, JL
Cheng, FC
Citation: G. Dryhurst et al., Potential roles of accelerated dopamine oxidation, altered glutathione metabolism, 5-S-cysteinyl-dopamine and its oxidative metabolites in the pathogenesis of Parkinson's disease, NEUROTOXIC FACTORS IN PARKINSON'S DISEASE AND RELATED DISORDERS, 2000, pp. 181-209
Citation: Xr. Jiang et al., Tryptamine-4,5-dione, a putative endotoxic metabolite of the superoxide-mediated oxidation of serotonin, is a mitochondrial toxin: Possible implications in neurodegenerative brain disorders, CHEM RES T, 12(5), 1999, pp. 429-436
Citation: Jl. Han et al., Inhibitors of mitochondrial respiration, iron (II), and hydroxyl radical evoke release and extracellular hydrolysis of glutathione in rat striatum and substantia nigra, potential implications to Parkinson's disease, J NEUROCHEM, 73(4), 1999, pp. 1683-1695